Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. State Department says COVID-19 vaccines shipped for all overseas workforce

Published 2021-04-20, 12:05 a/m
Updated 2021-04-20, 12:06 a/m
© Reuters. FILE PHOTO: FILE PHOTO: The State Department Building is pictured in Washington

By Humeyra Pamuk

WASHINGTON (Reuters) - The U.S. State Department has delivered COVID-19 vaccines to all of its eligible workforce deployed abroad as of Sunday and is expecting its entire workforce to have been fully vaccinated by mid-May, State Department officials said.

Earlier this year, the department came under fire from its staff as it struggled to vaccinate thousands of diplomats stationed in 220 overseas locations, considered a key human resource in advancing America's national security interests.

In internal cables dated late February, the department's senior leadership acknowledged supplies were falling short of the demand, the New York Times reported.

Secretary of State Antony Blinken, during his visit to Japan and South Korea last month, tried to reassure the embassy staff in virtual town halls that the department was working "as fast as it can" to get everyone vaccinated.

As the rollout of the vaccines within the United States accelerated, so did shipments to the State Department, one senior department official said.

"Within three or four weeks, whether they have Pfizer (NYSE:PFE) or Moderna, we will be complete with our vaccine program. So I would say easily by mid-May, anybody overseas that wanted a vaccine would be able to get one," said the official, who spoke on the condition of anonymity.

The department is also pressing ahead with its domestic vaccination campaign, but many employees are being inoculated through their states as vaccines become more widely available.

The State Department has a total of 76,711 staff deployed overseas and inside the United States, but the vaccination campaign also covers eligible family members and contractors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Biden, who took office on Jan. 20, set a goal of delivering 100 million shots into people’s arms within his first 100 days. That goal has since been doubled to 200 million.

The U.S. Centers for Disease Control and Prevention said it has administered more than 211 million doses of COVID-19 vaccine as of April 19. Over 85 million individuals have been fully vaccinated.

As the United States ramps up its inoculation campaign, more and more countries have been turning to Washington seeking vaccine supplies. It has already struck loan agreements with Mexico and Canada and, along with three of its closest Indo-Pacific partners, committed to supplying up to a billion vaccine doses across Asia by the end of 2022.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.